Walgreens Boots Alliance Inc. reports a 3.9% sales increase to $38.6 billion in Q2, outperforming expectations with a reduced net loss. CEO Tim Wentworth highlights strategic progr...
Walgreens Boots Alliance Inc. reports a 3.9% sales increase to $38.6 billion in Q2 of fiscal 2025, outperforming estimates. Despite a reduced net loss, challenges remain with weake...
Walgreens Boots Alliance Inc. announced a 3.9% increase in Q2 fiscal 2025 sales to $38.6 billion, exceeding expectations. Despite a net loss, improvements were noted in cost manage...
Walgreens Boots Alliance Inc. announced a 3.9% increase in Q2 sales to $38.6 billion, outperforming expectations. Despite a reduced net loss, challenges remain, including legal set...
Walgreens Boots Alliance Inc. reports a 3.9% sales increase to $38.6 billion in Q2 fiscal 2025, surpassing analysts' expectations. The company sees a reduced net loss and improved ...
Walgreens Boots Alliance Inc. reports a 3.9% sales increase to $38.6 billion in Q2 fiscal 2025, outperforming estimates. The net loss decreased significantly, with CEO Tim Wentwort...
Walgreens Boots Alliance Inc. reports a 3.9% increase in Q2 sales to $38.6 billion, beating estimates. The company also sees a reduced net loss, signaling positive financial adjust...
Walgreens Boots Alliance Inc. reports a 3.9% increase in Q2 sales to $38.6 billion, beating estimates. The company reduces net loss significantly, with CEO Tim Wentworth highlighti...
Walgreens Boots Alliance is set to be privatized by Sycamore Partners in a deal worth up to $23.7 billion, ending its nearly 100 years as a publicly traded company. The agreement i...
Walgreens Boots Alliance Inc. is reportedly nearing a $10 billion deal with Sycamore Partners to go private. The deal, aiming for completion by Thursday, could see Sycamore paying ...
Walgreens Boots Alliance Inc. may undergo a significant transformation with a potential buyout by Sycamore Partners, leading to a strategic split into three main businesses: Walgre...
Walgreens Boots Alliance Inc. is reportedly considering a buyout by Sycamore Partners that could lead to the company being split into three separate units: Walgreens U.S. retail, B...
Walgreens Boots Alliance Inc.'s shares fell over 12% after the DOJ filed a lawsuit accusing it of dispensing prescriptions for opioids without a legitimate medical purpose, potenti...
The U.S. Department of Justice has filed a lawsuit against Walgreens for allegedly dispensing millions of prescriptions without a legitimate medical purpose, including excessive qu...
Walgreens Boots Alliance Inc. experienced a 25% surge in its shares following a strong Q1 performance, with sales revenue up 7.5% year-over-year to $39.5 billion. CEO Tim Wentworth...
Walgreens Boots Alliance Inc. has reported a Q1 net loss of $265 million, a significant increase from the previous year's $67 million loss. This development underscores the challen...
Walgreens Boots Alliance Inc. is reportedly in talks to sell itself to New York-based private equity firm Sycamore Partners, a move that could take the company private after a deca...
